Congress Materials – American Association for Cancer Research (AACR 2026)
2026 American Association for Cancer Research | Apr 17-22 | San Diego, CA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Advancing Insights Into Disease Biology of Non-Muscle Invasive Bladder Cancer (NMIBC) Through Comprehensive Multi-Omics Analysis
Siew Kee Low, Yoshiyuki Nagumo, Xuesong Lyu, Jiarui Zhang, Jie Zhao, Kozaburo Tanuma, Satoka Kinase, Karen Urtishak, Neil Beeharry, Shibu Thomas, Longen Zhou, Hiroyuki Nishiyama
This document will be available on April 17 2026
Differential In Vitro Activity of Amivantamab, Cetuximab, and Panitumumab Against EGFR ECD Resistance Mutations
Stacey L. Lehman, Himanshu Gupta, Rosa M.F. Cardoso, Laura A. Struzyna, Stephen W. Jarantow, Xuesong Lyu, Elsie Samakai, Emrullah Yilmaz, Sanjib Chowdhury, Joshua C. Curtin, Bharvin Patel
This document will be available on April 17 2026
Digital Spatial Profiling Reveals Immune Heterogeneity Across Tumor and Stromal Compartments in Hepatocellular Carcinoma
Min Qing, Qibiao Wu, Xuesong Lyu, Tao Chen, Mingxuan Xia, Joshua J. Rusbuldt, Denis Smirnov, Flora Berisha, Longen Zhou, Chia-Jui Yen
This document will be available on April 17 2026
Distinct Tumor Microenvironmental Landscapes Define Molecular Subtypes in Non–Muscle-Invasive Bladder Cancer
Songjun Xu, Matthew H.V. Byrne, Jiarui Zhang, Ahmad Alalti, Devika Agarwal, Neil Beeharry, Olesya Chornoguz, Kyla Dooley, Kin Cheung Lee, Shuwei Li, Guneet Walia, Tommaso Mansi, Joel Greshock, Calliope Dendrou, Freddie C. Hamdy, Lisa Browning, Dan J. Woodcock, Patrick Wilkinson, Shibu Thomas
This document will be available on April 17 2026
Impact of First-Line (1L) Amivantamab-Lazertinib vs Osimertinib on Second-Line (2L) Progression-Free Survival (PFS)
David R. Spigel, Danny Nguyen, Hidetoshi Hayashi, Byoung Chul Cho, Sanjay Popat, James Chih-Hsin Yang, Scott Owen, Antonio Passaro, Clarissa Baldotto, Julian Kam, Seema Sethi, Sujay Shah, Jiarui Zhang, Joshua C. Curtin, Nicolas Girard, William N. William Jr
This document will be available on April 17 2026
Integrative Multi-Omics Characterization and AI-Driven Biomarker Discovery for NSCLC Stage III Outcomes
Katherina C. Chua, Yun-Ching Chen, Ariel Chen, Stewart Bates, Mehdi Pirooznia, Assieh Saadatpour
This document will be available on April 17 2026
JNJ-95437446: Discovery and Preclinical Characterization of an Amivantamab-Based EGFR/MET-ADC for Solid Tumor Indications
Benjamin Henley, Linxiao Chen, Megan Siani, Swetha Rao, Yi Fan, Kristen Wiley, Steve Pomerantz, Shalom Goldberg, Onyi Irrechukwu, Simone Buraschi, Suresh Kumar Swaminathan, Krista Burke, Tammy Bush, Bethany Mattson, Heather Deutsch, Gerald Chu, Jacalyn Clawson, Wan Cheung, Joshua M. Bauml, Ulrike Philippar, Smruthi Vijayaraghavan
This document will be available on April 17 2026
Project CoMMunity: A local learning network deployed to address multiple myeloma care gaps in two communities
Cesar Rodriguez, John T Mckay, Abdur Rahman Jabir, Alex Lieberman-Cribbin, Sean Paul Ormond, Kimberly Brunisholz, Kristi Cohn, Dianna S Howard
This document will be available on April 17 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.